The retroviral vector family: something for everyone

Area of Science:

• * Molecular Biology
• * Gene Therapy
• * Virology

Background:

• * Retroviral research evolved over 30 years, transforming pathogenic viruses into therapeutic tools.
• * Human immunodeficiency virus (HIV) exemplifies this transition from pandemic threat to cell therapy vector.
• * Early gene therapy trials faced challenges with retroviral vector genotoxicity due to insertional mutagenesis.

Purpose of the Study:

• * To review the evolution of retroviral vectors from pathogenic viruses to sophisticated gene therapy tools.
• * To highlight advancements in vector design addressing safety and efficacy concerns.
• * To showcase current applications including stem cell generation and RNA interference.

Main Methods:

• * Development of split-vector systems separating particle formation and transgene expression genes.
• * Engineering of self-inactivating vectors with reduced cellular promoter strength to mitigate genotoxicity.
• * Creation of inducible systems for controlled gene expression.
• * Integration of CRISPR-Cas9 gene editing technologies for advanced applications.

Main Results:

• * Successful conversion of retroviruses, including HIV, into safe and effective gene therapy vectors.
• * Overcoming insertional mutagenesis through improved vector designs like self-inactivating vectors.
• * Development of versatile vectors for induced pluripotent stem cells and RNA interference.
• * Application of CRISPR-Cas9 for genome-wide screening and efficient gene editing delivery.

Conclusions:

• * Retroviral vectors have matured into powerful and adaptable tools for diverse biomedical applications.
• * Continuous innovation in vector design has significantly enhanced safety and therapeutic potential.
• * Emerging technologies like CRISPR-Cas9 further expand the capabilities of gene editing and delivery systems.